Concepedia

Sven Nylander

SN

Statistics

Publications

41

Citations

2.6K

H-Index

26

Active since

1994

Affiliations

AstraZeneca (Sweden)(Current)

Baylor College of Medicine

The University of Texas Medical Branch at Galveston

AstraZeneca (United Kingdom)

Linköping University Hospital

Sven Nylander is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and antiplatelet therapy.

ORCID

Publications per year

1994–2022

41

Publications

41

Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat

A.‐L. Ungell, Sven Nylander, Sara Bergstrand et al. · Journal of Pharmaceutical Sciences · 1998 · 256 citations

, , +15

Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1

Duncan Armstrong, Claire Summers, Lorna Ewart et al. · Journal of Cardiovascular Pharmacology and Therapeutics · 2014 · 240 citations

, , +12

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Ann Wittfeldt, Håkan Emanuelsson, Gunnar Brandrup‐Wognsen et al. · Journal of the American College of Cardiology · 2013 · 196 citations

, , +10

Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans

Hans Lennernäs, Sven Nylander, A.‐L. Ungell · Pharmaceutical Research · 1997 · 170 citations

, , +4

Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism

Sven Nylander, Eti Alessandra Femia, Mariangela Scavone et al. · Journal of Thrombosis and Haemostasis · 2013 · 150 citations · Full text

, , +14

1–5 of 41